• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用临床前模型对天然产物作为治疗或化学预防剂对抗头颈部鳞状细胞癌细胞的综合综述。

A Comprehensive Review of Natural Products as Therapeutic or Chemopreventive Agents against Head and Neck Squamous Cell Carcinoma Cells Using Preclinical Models.

作者信息

Liew Yoon Xuan, Karen-Ng Lee Peng, Vincent-Chong Vui King

机构信息

Oral Cancer Research & Coordinating Centre (OCRCC), Faculty of Dentistry, University of Malaya, Kuala Lumpur 50603, Malaysia.

Department of Oral Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

出版信息

Biomedicines. 2023 Aug 23;11(9):2359. doi: 10.3390/biomedicines11092359.

DOI:10.3390/biomedicines11092359
PMID:37760799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10525836/
Abstract

Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that arises from the epithelium lining of the oral cavity, hypopharynx, oropharynx, and larynx. Despite the advancement of current treatments, including surgery, chemotherapy, and radiotherapy, the overall survival rate of patients afflicted with HNSCC remains poor. The reasons for these poor outcomes are due to late diagnoses and patient-acquired resistance to treatment. Natural products have been extensively explored as a safer and more acceptable alternative therapy to the current treatments, with numerous studies displaying their potential against HNSCC. This review highlights preclinical studies in the past 5 years involving natural products against HNSCC and explores the signaling pathways altered by these products. This review also addresses challenges and future directions of natural products as chemotherapeutic and chemoprevention agents against HNSCC.

摘要

头颈部鳞状细胞癌(HNSCC)是一种起源于口腔、下咽、口咽和喉部上皮衬里的癌症。尽管目前的治疗方法不断进步,包括手术、化疗和放疗,但患有HNSCC的患者的总体生存率仍然很低。这些不良结果的原因是诊断延迟和患者获得性治疗耐药性。天然产物已被广泛探索作为当前治疗的一种更安全、更可接受的替代疗法,大量研究显示了它们对HNSCC的潜力。这篇综述重点介绍了过去5年中涉及天然产物抗HNSCC的临床前研究,并探讨了这些产物改变的信号通路。这篇综述还讨论了天然产物作为抗HNSCC的化疗和化学预防剂所面临的挑战和未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10525836/b52eb6a756c5/biomedicines-11-02359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10525836/4d74a40a1392/biomedicines-11-02359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10525836/b52eb6a756c5/biomedicines-11-02359-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10525836/4d74a40a1392/biomedicines-11-02359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6156/10525836/b52eb6a756c5/biomedicines-11-02359-g002.jpg

相似文献

1
A Comprehensive Review of Natural Products as Therapeutic or Chemopreventive Agents against Head and Neck Squamous Cell Carcinoma Cells Using Preclinical Models.使用临床前模型对天然产物作为治疗或化学预防剂对抗头颈部鳞状细胞癌细胞的综合综述。
Biomedicines. 2023 Aug 23;11(9):2359. doi: 10.3390/biomedicines11092359.
2
Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines.头颈部鳞状细胞癌:危险因素、分子改变、免疫学与肽疫苗
Int J Pept Res Ther. 2022;28(1):19. doi: 10.1007/s10989-021-10334-5. Epub 2021 Dec 8.
3
Head and neck cancer: Current challenges and future perspectives.头颈部癌症:当前的挑战与未来展望。
Adv Cancer Res. 2021;152:67-102. doi: 10.1016/bs.acr.2021.05.002. Epub 2021 Jun 16.
4
Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review.治疗头颈部鳞状细胞癌的潜在替代治疗方法:综述。
Cancer Control. 2023 Jan-Dec;30:10732748231185003. doi: 10.1177/10732748231185003.
5
A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.头颈部癌症有前途的天然化学预防剂的综述。
Cancer Prev Res (Phila). 2018 Aug;11(8):441-450. doi: 10.1158/1940-6207.CAPR-17-0419. Epub 2018 Mar 30.
6
Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors.接受检查点抑制剂治疗的头颈部黏膜鳞状细胞癌患者的结局。
JAMA Otolaryngol Head Neck Surg. 2022 Oct 1;148(10):918-926. doi: 10.1001/jamaoto.2022.2284.
7
Evidence-based radiation oncology in head and neck squamous cell carcinoma.头颈部鳞状细胞癌的循证放射肿瘤学
Radiother Oncol. 2007 Oct;85(1):156-70. doi: 10.1016/j.radonc.2007.04.002. Epub 2007 May 4.
8
Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma.长链非编码RNA在头颈部鳞状细胞癌耐药机制中的新作用
Front Oncol. 2022 Aug 1;12:965628. doi: 10.3389/fonc.2022.965628. eCollection 2022.
9
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.头颈部鳞状细胞癌:免疫调节癌症治疗的基因组学和新兴生物标志物。
Semin Cancer Biol. 2018 Oct;52(Pt 2):228-240. doi: 10.1016/j.semcancer.2018.01.008. Epub 2018 Jan 31.
10
DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity.DAHANCA 28 研究:同期顺铂和尼莫佐胺增敏超分割加速放疗(HART-CN)治疗 HPV/p16 阴性局部晚期口咽、下咽、喉及口腔鳞癌的 I/II 期可行性研究。
Radiother Oncol. 2020 Jul;148:65-72. doi: 10.1016/j.radonc.2020.03.025. Epub 2020 Mar 28.

引用本文的文献

1
Antibacterial, Photoprotective, Anti-Inflammatory, and Selected Anticancer Properties of Honokiol Extracted from Plants of the Genus and Used in the Treatment of Dermatological Problems-A Review.从木兰属植物中提取的厚朴酚的抗菌、光保护、抗炎及某些抗癌特性及其在皮肤病治疗中的应用——综述
Int J Mol Sci. 2025 Sep 8;26(17):8737. doi: 10.3390/ijms26178737.
2
Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses.病毒战:释放工程化溶瘤病毒以智取癌症防御。
Front Immunol. 2025 Aug 25;16:1618751. doi: 10.3389/fimmu.2025.1618751. eCollection 2025.
3
Recent Advances in the Application of Cucurbitacin B as an Anticancer Agent.

本文引用的文献

1
Kaempferol and Fisetin-Related Signaling Pathways Induce Apoptosis in Head and Neck Cancer Cells.山奈酚和非瑟酮相关信号通路诱导头颈部癌细胞凋亡。
Cells. 2023 Jun 6;12(12):1568. doi: 10.3390/cells12121568.
2
Protocatechuic Acid-Based Supramolecular Hydrogel Targets SerpinB9 to Achieve Local Chemotherapy for OSCC.原儿茶酸基超分子水凝胶靶向 SerpinB9 实现 OSCC 的局部化疗。
ACS Appl Mater Interfaces. 2022 Aug 17;14(32):36379-36394. doi: 10.1021/acsami.2c07534. Epub 2022 Jul 29.
3
C-Myc Expression in Oral Squamous Cell Carcinoma: Molecular Mechanisms in Cell Survival and Cancer Progression.
葫芦素B作为抗癌剂应用的最新进展
Int J Mol Sci. 2025 Aug 19;26(16):8003. doi: 10.3390/ijms26168003.
4
Editorial of Special Issue "Oral Cancer: From Pathophysiology to Novel Therapeutic Approaches".《“口腔癌:从病理生理学到新型治疗方法”特刊社论》
Biomedicines. 2023 Oct 11;11(10):2748. doi: 10.3390/biomedicines11102748.
口腔鳞状细胞癌中的C-Myc表达:细胞存活和癌症进展的分子机制
Pharmaceuticals (Basel). 2022 Jul 19;15(7):890. doi: 10.3390/ph15070890.
4
Discovery of potent immune-modulating molecule taccaoside A against cancers from structures-active relationships of natural steroidal saponins.从天然甾体皂甙的结构-活性关系发现具有强效免疫调节作用的抗癌分子塔卡皂苷 A。
Phytomedicine. 2022 Sep;104:154335. doi: 10.1016/j.phymed.2022.154335. Epub 2022 Jul 11.
5
Trichodermin inhibits the growth of oral cancer through apoptosis-induced mitochondrial dysfunction and HDAC-2-mediated signaling.曲古抑菌素通过诱导凋亡引起的线粒体功能障碍和HDAC-2介导的信号传导来抑制口腔癌的生长。
Biomed Pharmacother. 2022 Sep;153:113351. doi: 10.1016/j.biopha.2022.113351. Epub 2022 Jul 1.
6
Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects Inhibition of Multiple Cellular Pathways.提取物及其生物活性成分肉桂醛显示出抗肿瘤作用——对多种细胞途径的抑制作用。
Front Pharmacol. 2022 Jun 2;13:918479. doi: 10.3389/fphar.2022.918479. eCollection 2022.
7
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents.天然产物靶向癌症信号通路:探索有前途的抗癌药物。
Biomed Pharmacother. 2022 Jun;150:113054. doi: 10.1016/j.biopha.2022.113054. Epub 2022 Apr 30.
8
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.基于类器官的筛选用于表观遗传抑制剂,这些抑制剂能刺激抗原呈递并增强 T 细胞介导的细胞毒性。
Nat Biomed Eng. 2021 Nov;5(11):1320-1335. doi: 10.1038/s41551-021-00805-x. Epub 2021 Nov 1.
10
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.术后顺铂化疗联合放疗优于西妥昔单抗联合放疗和单纯放疗:奥地利头颈部癌症登记处的 AGMT 分析。
Wien Klin Wochenschr. 2021 Nov;133(21-22):1131-1136. doi: 10.1007/s00508-021-01939-3. Epub 2021 Sep 15.